IESE (España)
-
Genmedi: How to Value a New Company for an Upcoming Round of Financing - Teaching Note
Liechtenstein, Heinrich; Kolarova, LenkaTeaching Note ET-34-EEntrepreneurship, FinanceEvery venture capital and private equity deal involves determining the value of the company. This is one of the most important-and most difficult-tasks faced by an investor (and an entrepreneur), and skill is required when using the various methods for valuing a company. In March 2019, the investors in LifeCycle Ltd.-a technology company based in Shanghai, China-set up a new company, Genmed, to capitalize on an innovative technology for biologica...Starting at €0.00
-
Investment Strategies and Berkshire Hathaway
Palencia, LuisCase C-734-EAccounting and ControlAn average investor, Josu Short, reviews Berkshire Hathaway's 13-plus-one points of the "contract with shareholders" present in each of the company's annual reports. Apparent inconsistencies and financial paradoxes are presented.Starting at €8.20
-
Nasser Press
Kadach, Igor; Palencia, LuisCase ASN-83-EEntrepreneurship, StrategyThe owner of a mid-size printing company based in New Jersey has to decide whether to accept an offer of a large publishing house who during the 2008 crisis had endangered the future of the company by abruptly reducing the volume of business. If he now accepted his proposal, and due to capacity constraints, he would have to drop some smaller customers, reducing diversification; in addition, the owner feels indebted to these small businesses becau...Starting at €8.20
-
Genmedi: How to Value a New Company for an Upcoming Round of Financing
Liechtenstein, Heinrich; Kolarova, LenkaCase E-207-EEntrepreneurship, FinanceEvery venture capital and private equity deal involves determining the value of the company. This is one of the most important-and most difficult-tasks faced by an investor (and an entrepreneur), and skill is required when using the various methods for valuing a company. In March 2019, the investors in LifeCycle Ltd.-a technology company based in Shanghai, China-set up a new company, Genmed, to capitalize on an innovative technology for biologica...Starting at €8.20